Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of JK07 in adults with chronic heart failure
CTR20242392Phase 2Active
- Sponsor
- Salubris Biotherapeutics
- Start
- Jul 2024
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Monoclonal Antibodies → Antibody-Based Therapeutics, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of JK07 in chronic heart failure (CHF), sponsored by Salubris Biotherapeutics. Started Jul 2024; status: active.
02
Drugs
JK07
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on CTR20242392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242392.